In a very recent study, high expression of B7-H4 (VTCN1), a member of the B7 family, was associated with a poorer prognosis in AdCC, regardless of clinical stage and histologic subtype. The gene discussed is VTCN1; the disease is adrenocortical carcinoma, hereditary.